Home Search

COVID-19 - search results

If you're not happy with the results, please do another search
long COVID

New research studies to tackle Long COVID in the community

Four new research studies looking into Long COVID in the community will receive funding worth £18.5 million from UK Research and Innovation (UKRI) and the National Institute for Health Research (NIHR).
mRNA vaccine, cancer treatment

Can an mRNA vaccine be used to cure some types of cancer?

COVID brought the idea of mRNA vaccines to the attention of the world - now, cancer researchers are investigating how a similar vaccine could stop tumours in a single treatment.
the south african mutation, pfizer

Pfizer vaccine can still prevent death from the South African mutation

The Pfizer and BioNTech vaccine appears to be significantly less efficient against the South African mutation, but can still stop hosts from experiencing severe COVID and dying from the virus.
COVID cases in hospitals, lockdown

REACT study: COVID cases in hospitals “higher than at the peak of the first...

New data from the REACT study finds that the number of COVID cases in hospitals is higher than it was in April 2020, but that infection rates are substantially decreasing across the country.
coronavirus human challenge study

UK receives ethics approval for first coronavirus human challenge study

The UK has received approval from the clinical trials ethics body for the world's first coronavirus human challenge study.
Moderna

European Commission approves second Moderna contract for 300m vaccines

The European Commission has approved a second contract with Moderna to secure an additional 300 million vaccine doses.
suicide rates for young women, japan suicide

Suicide rates for young women are increasing in Japan

For one decade, Japan worked to bring down suicide rates across the country - now, COVID-19 threatens to reverse this progress by creating a new category of people who are vulnerable.
HERA incubator, manufacturing

Commission launches “HERA Incubator” project to fight COVID mutations

The European Commission today (17 February) launched the "HERA Incubator", as both a "blueprint" for long-term health emergencies and a way to stop COVID-19 mutations.
Premature Ovarian Insufficiency, POI

Suffering with Premature Ovarian Insufficiency (POI) in the workplace

Dr Ghazala Aziz-Scott, a specialist in Women’s health at The Marion Gluck Clinic, explores how Premature Ovarian Insufficiency (POI) can affect working women and how they can discuss this problem with their employer.
Johnson & Johnson, european

The Johnson & Johnson COVID vaccine works with just one dose

The New Jersey-based drugmaker created a COVID-19 vaccine that works at 66% efficiency in one dose, which they have sent to the EU for approval.
two covid tests a week, school

School children to be offered two COVID tests a week after lockdown

A leaked plan for the re-opening of schools lists a measure to provide two COVID tests a week, to school children who have returned to education.
climate ambition

The priorities to increase global climate ambition

Open Access Government spoke to Oliver Bolton, CEO of Earthly about the priorities to increase global climate ambition in line with the Paris Agreement.
diabetes referrals

Is the UK heading for a “perfect storm” of diabetes referrals?

Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
landscape of microbiology, dr elica moss

Changing the landscape of microbiology

Here, we interview Dr Elica M Moss, Research Assistant Professor at Alabama A&M University, about her work and how it seeks to change the landscape of microbiology.
technology-enabled care services

How TECS have supported the NHS pre, during and post-COVID

Zillah Moore, Director at Tunstall Healthcare, discusses the role of technology-enabled care services and remote patient monitoring in reducing delayed discharge from hospitals and providing much-needed assistance to the NHS.
COVID vaccines in 2021, low income

70% of available COVID vaccines in 2021 have been pre-ordered

Currently, 16% of the global population have pre-ordered 70% of available COVID vaccines in 2021 - a group of virus experts now warn that COVID will keep evolving unless low income countries can access vaccines.
elevated anxiety, adult

Researchers identify young adults who are facing elevated anxiety

The study looks at behaviour traits at the age of 15, that signal if individuals could be at risk of elevated anxiety three years in the future.
side effects of the astrazeneca vaccine, covid

What are the side effects of the AstraZeneca vaccine?

Here, we use science to dissect some of the rumours about the side effects of the AstraZeneca and Oxford University vaccine.
work is flexible

The future of work is flexible

Scott Erwin, CEO and Founder of HireHand, explores the future of flexible working and how businesses may approach their staffing post-pandemic.
creating AI, robot

Scientists are creating AI that can detect “anger or fear” in a public area

Korean scientists are creating an AI called 5G-I-VEmoSYS, which can read human emotions via wireless signals and body movement.

Follow Us

Advertisements